Synonyms: | |
Status: | Approved (2001) |
Entry Type: | Small molecule |
Molecule Category: | UKNOWN |
ATC: | C02KX01 |
UNII: | XUL93R30K2 |
InChI Key | GJPICJJJRGTNOD-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C27H29N5O6S |
Molecular Weight | 551.63 |
AlogP | 4.2 |
Hydrogen Bond Acceptor | 10.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 10.0 |
Polar Surface Area | 145.65 |
Molecular species | ACID |
Aromatic Rings | 4.0 |
Heavy Atoms | 39.0 |
Action | Mechanism of Action | Reference |
---|---|---|
ANTAGONIST | Endothelin receptor, ET-A/ET-B antagonist | DailyMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Endothelin receptor
|
- | 5-1585 | 40-72 | 7-8 | 23 | |
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group I
Nuclear hormone receptor subfamily 1 group I member 2
|
8900-14100 | - | - | - | - | |
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | 22000-38100 | - | - | - | |
Transporter
Primary active transporter
ATP-binding cassette
ABCC subfamily
|
- | 22000 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Hypertension, Pulmonary | 4 | D006976 | ClinicalTrials |
Hypertension | 4 | D006973 | ClinicalTrials |
Hypertension, Pulmonary | 4 | D006976 | ClinicalTrials |
Diabetes Mellitus, Type 2 | 3 | D003924 | ClinicalTrials |
Persistent Fetal Circulation Syndrome | 3 | D010547 | ClinicalTrials |
Scleroderma, Systemic | 3 | D012595 | ClinicalTrials |
Eisenmenger Complex | 3 | D004541 | ClinicalTrials |
Heart Septal Defects, Atrial | 3 | D006344 | ClinicalTrials |
Idiopathic Pulmonary Fibrosis | 3 | D054990 | ClinicalTrials |
Ulcer | 3 | D014456 | ClinicalTrials |
Optic Neuropathy, Ischemic | 3 | D018917 | ClinicalTrials |
Melanoma | 2 | D008545 | ClinicalTrials |
Hypoplastic Left Heart Syndrome | 2 | D018636 | ClinicalTrials |
Hernias, Diaphragmatic, Congenital | 2 | D065630 | ClinicalTrials |
Liver Cirrhosis | 2 | D008103 | ClinicalTrials |
Hepatopulmonary Syndrome | 2 | D020065 | ClinicalTrials |
Pulmonary Disease, Chronic Obstructive | 2 | D029424 | ClinicalTrials |
Asthma | 2 | D001249 | ClinicalTrials |
Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
Mitral Valve Stenosis | 1 | D008946 | ClinicalTrials |
Heart Failure | 1 | D006333 | ClinicalTrials |
Glaucoma | 1 | D005901 | ClinicalTrials |
Diabetes Mellitus | 1 | D003920 | ClinicalTrials |
Fever | 1 | D005334 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 51450 |
ChEMBL | CHEMBL957 |
DrugBank | DB00559 |
DrugCentral | 392 |
EPA CompTox | DTXSID7046627 |
FDA SRS | XUL93R30K2 |
Human Metabolome Database | HMDB0014699 |
Guide to Pharmacology | 3494 |
PDB | K86 |
PharmGKB | PA10034 |
SureChEMBL | SCHEMBL4218 |
ZINC | ZINC000001538857 |